Advertisement

Topics

Illumina Company Profile

16:43 EDT 22nd September 2017 | BioPortfolio

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our technology platform also extends to other applications such as high-throughput screening of pharmaceutical compounds and chemical detection.

Location

9390 Towne Centre Dr. Suite 200
San Diego
CA
92024
United States of America

Contact

Phone: 858 587 4297
Email: investor@illumina.com


News Articles [82 Associated News Articles listed on BioPortfolio]

IDT partners with Illumina

Integrated DNA Technologies (IDT) announced a broad partnership with Illumina, Inc. to provide improved library preparation multiplexing and target enrichment solutions for the next generation sequenc...

Helix, Illumina Partner to Support Startups for DNA-Driven Consumer Products

Personal genomics company Helix and Illumina are partnering to support consumer genomics startups. Helix is teaming up with Illumina Accelerator to provide resources and support for innovative entrepr...

Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups

Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at...

Illumina, Telegraph Hill Partners launch Verogen

Illumina announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen. The independent new company has certain exclusive right...

Illumina to Webcast Live Presentation at the Goldman Sachs Global Healthcare Conference

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company’s presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, Califor...

Insider Selling: Illumina, Inc. (ILMN) Director Sells 15,000 Shares of Stock

Illumina, Inc. Director Jay T. Flatley sold 15,000 shares of Illumina stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $175.53, for a total transaction of $2,6...

Illumina plans expansion in China, CEO says

Illumina is planning to expand operations in China, its biggest market outside of the US, following double-digit growth in th -More- 

Illumina names Mark Van Oene chief commercial officer

Illumina announced that Mark Van Oene has been named chief commercial officer. Van Oene was previously Illumina’s senior vice president of the Americas region and subsequently named interim chief co...

Drugs and Medications [0 Results]

None

PubMed Articles [71 Associated PubMed Articles listed on BioPortfolio]

Strategies for processing and quality control of Illumina genotyping arrays.

Illumina genotyping arrays have powered thousands of large-scale genome-wide association studies over the past decade. Yet, because of the tremendous volume and complicated genetic assumptions of Illu...

StrandScript: Evaluation of Illumina Genotyping Array Design and Strand Correction.

After the introduction of high-throughput sequencing, genotyping arrays continue to be a viable source for conducting large-scale genetic studies. Currently, Illumina is one of the largest genotyping ...

A novel post hoc method for detecting index switching finds no evidence for increased switching on the Illumina HiSeq X.

High throughput sequencing using the Illumina HiSeq platform is a pervasive and critical molecular ecology resource, and has provided the data underlying many recent advances. A recent study has sugge...

Genome Sequencing of Steroid-Producing Bacteria with Illumina Technology.

Illumina technology is widely used for bacterial whole-genome sequencing due to its simplicity, cheapness, reliability, and abundant software for manipulation with raw data. Illumina technology belong...

Acclimatization of a mixed-animal manure inoculum to the anaerobic digestion of Axonopus compressus reveals the putative importance of Mesotoga infera and Methanosaeta concilii as elucidated by DGGE and Illumina MiSeq.

In this study, a multifarious microbial mix from different sources is acclimatized over a period of three months to digesting cowgrass, and the changes in the community structure are examined with bot...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (nasopharynx, adenoids and middle ear fluid) of otitis media with effusion (OME) patients is c...

Comprehensive DNA Methylation Profiling in Crohn's Disease

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed i...

Microbiota Upper Respiratory Tract

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (URT) (nose, nasopharynx and sinuses) of chronic rhinosinusitis (CRS) patients is disturbed co...

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

This is a prospective, non-randomized and multicenter study designed to compare biological features between pN0 triple negative breast cancer (TNBC) with size ≤ 10 mm (pT1a/b) versus pT1...

Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA

MiRNAs are single-stranded small non-coding RNAs that act on specific mRNAs to regulate the gene expression. Studies have suggested that miRNAs influence cellular activities in the uterus...

Companies [12 Associated Companies listed on BioPortfolio]

Illumina

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our tec...

Illumina Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and functi...

GRAIL

GRAIL is focused on detecting cancer at an early-stage, when it can be cured. The company secured over $100 million in Series A financing from Illumina, Inc. and ARCH Venture Part...

Illumina, Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and ...

bioMérieux & Illumina

More Information about "Illumina" on BioPortfolio

We have published hundreds of Illumina news stories on BioPortfolio along with dozens of Illumina Clinical Trials and PubMed Articles about Illumina for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Illumina Companies in our database. You can also find out about relevant Illumina Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record